Skip to main content
Clinical Trials/NCT05192031
NCT05192031
Active, Not Recruiting
N/A

Implementation of Smoking Cessation Support During Lung Cancer Workup: a Pragmatic, Cluster-randomised Controlled Trial and an Interview-based Study of Patients' and Healthcare Professionals' Experiences

Vejle Hospital1 site in 1 country295 target enrollmentMarch 9, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Suspected Lung Cancer
Sponsor
Vejle Hospital
Enrollment
295
Locations
1
Primary Endpoint
Proportion of patients making an attempt at smoking cessation during lung cancer workup
Status
Active, Not Recruiting
Last Updated
last year

Overview

Brief Summary

The aim of the present project is to implement smoking cessation support in hospital-based lung cancer workup. The effect on 1) patients' smoking cessation attempts, motivation, quality of life and psychosocial consequences of lung cancer workup as well as 2) hospitals' number of referrals to municipality-based smoking cessation programmes will be evaluated in a pragmatic, cluster-randomised controlled setup, where participating hospitals will be assigned to the intervention arm (implementation of smoking cessation support) or the control arm (usual practice). Patients' and healthcare professionals' experiences with and barriers towards smoking cessation support will be explored in an interview-based, qualitative study.

Registry
clinicaltrials.gov
Start Date
March 9, 2022
End Date
December 31, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Referred to lung cancer workup at participating hospital
  • Able to speak and understand Danish

Exclusion Criteria

  • Unable to complete electronic questionnaires

Outcomes

Primary Outcomes

Proportion of patients making an attempt at smoking cessation during lung cancer workup

Time Frame: 6 weeks after baseline

Binary outcome (Attempt: yes, no)

Secondary Outcomes

  • Proportion of patients who are not smoking at the time of measurement(6 weeks, 3, 6, and 12 months after baseline)
  • Quality of life as measured by the 36 item Short Form Survey (SF-36)(6 weeks, 3, 6, and 12 months after baseline)
  • Hospitals' number of referrals to municipality-based smoking cessation programmes(Change from one year before to one year after intervention)
  • Motivation to quit smoking(6 weeks, 3, 6, and 12 months after baseline)
  • Psychosocial consequences of lung cancer workup(6 weeks after baseline)

Study Sites (1)

Loading locations...

Similar Trials